Related Experiment Video
Updated: May 4, 2026
07:43
Author Spotlight: Optimizing CFPS Systems for Synthetic Cell Construction
Published on: April 19, 2024
4.2K
Human cell extract-derived cell-free systems for virus synthesis.
Tominari Kobayashi1, Kodai Machida, Hiroaki Imataka
1Department of Materials Science and Chemistry, Graduate School of Engineering, University of Hyogo, Himeji, Japan.
Methods in Molecular Biology (Clifton, N.J.)
|January 8, 2014
Summary
Cell-free synthesis of infectious Encephalomyocarditis virus (EMCV) was achieved using a HeLa cell extract system. This method enables efficient viral replication studies and antiviral drug development.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- Cell-free synthesis offers a controlled environment for studying viral mechanisms.
- Encephalomyocarditis virus (EMCV) serves as a model for viral replication studies.
Purpose of the Study:
- To describe the cell-free synthesis of infectious Encephalomyocarditis virus (EMCV).
- To establish a method for elucidating viral replication mechanisms.
- To facilitate the development of novel antiviral drugs.
Main Methods:
- Utilizing a HeLa cell extract-derived in vitro protein expression system.
- Synthesizing EMCV from both RNA and DNA templates.
- Employing a dialysis system for RNA-based synthesis with a hammerhead ribozyme.
- Using T7 RNA polymerase for DNA-based synthesis from a plasmid containing EMCV cDNA.
Main Results:
- Successful progressive synthesis of EMCV particles from synthetic EMCV RNA.
- Demonstrated EMCV synthesis from a DNA template using T7 RNA polymerase in cell extract.
- Established a functional cell-free system for infectious virus production.
Conclusions:
- Cell-free synthesis is a viable method for producing infectious EMCV.
- This system is valuable for understanding viral replication processes.
- The developed method supports the discovery and development of antiviral therapies.
